Browse the evidence

The incidence of gastrointestinal adverse effects with tirzepatide was similar to that of semaglutide.

Tirzepatide may have a similar safety profile regarding gastrointestinal effects compared to semaglutide.

Interim results on industry-led food reformulation did not meet the countries’ targets.

Practitioners should be aware that current reformulation efforts may not be effective in achieving public health targets.

Information asymmetries exist between food industry and policy makers.

Policy makers should seek independent data to inform nutrition policies.

The data provided by food industry actors represent a distorted snippet of the marketing intelligence system.

Practitioners should critically evaluate data from food industry sources before implementing policies.

Four nights of sleep restriction did not alter resting energy metabolism in postmenopausal women.

Practitioners can note that while insulin sensitivity and fat oxidation are affected, resting metabolism remains stable with sleep restriction.

There was no statistically significant difference in total Medicare spending between the intervention and control groups (difference, -$133; P = .89).

Practitioners should note that intensive lifestyle interventions may not lead to reduced total Medicare spending.

Allowing Medicare coverage of anti-obesity medications could increase annual Part D costs by $3.1 billion or $6.1 billion depending on the percentage of newly eligible patients prescribed the drugs.

Practitioners should be aware of the potential financial implications of Medicare coverage for anti-obesity medications.

The marginal costs of Medicare coverage for anti-obesity drugs could decrease by up to 62.5% if products are approved for additional indications.

Practitioners should consider the potential for reduced costs if additional indications for anti-obesity drugs are approved.

The policy change of covering anti-obesity medications is likely to increase Medicare costs by low to middle tens of billions of dollars over ten years.

Practitioners should prepare for the potential long-term financial impact of Medicare's coverage of anti-obesity medications.

Nose-to-brain (N2B) pathways can address limitations of the subcutaneous route for GLP-1 RAs.

Practitioners should explore N2B pathways as a viable alternative for delivering GLP-1 RAs.

Obesity prevalence is projected to grow by 40% in the next decade.

Health professionals should prepare for increased obesity-related health issues.

There were no significant changes in peak VO2 or other cardiovascular measures with HU6 treatment.

HU6 may not improve cardiovascular function despite weight loss.

25,215 adverse event reports related to tirzepatide were identified, predominantly in the 65 to 85 age group.

Healthcare providers should be aware of the high volume of AE reports in older adults using tirzepatide.

Novel adverse event signals include thyroid mass, medullary thyroid carcinoma, and conditions affecting the reproductive system and breast.

Clinicians should be vigilant for these specific adverse events in patients treated with tirzepatide.

A biomimetic and comparative approach can provide insights into human ageing processes.

Practitioners should consider integrating insights from diverse species to enhance understanding of ageing.

Multiple hallmarks of ageing have been identified that are fundamental across taxa.

Understanding these hallmarks can guide research and interventions in age-related diseases.

There is a need for renewed focus in the pathophysiology of ageing and age-related disease.

Researchers should explore new avenues in the study of ageing and related diseases.

Nonalcoholic fatty liver disease (NAFLD) affects approximately 25% of the global population.

Healthcare providers should be aware of the high prevalence of NAFLD in their patient populations.

The direct to consumer genetic testing market is estimated to total about $100 million in 2017.

Practitioners should be aware of the significant financial scale of the DTC genetic testing market.

The need for more effective treatments for obesity is obvious due to the far-reaching effects of the condition.

Healthcare providers should prioritize finding effective obesity treatments.

Ingestion of deuterated water results in 2 H enrichment of the body water pool, which is incorporated into tissue proteins.

This highlights a novel approach to studying protein synthesis in muscle tissue.

There is limited clinical trial data on the safety and efficacy of anti-obesity medications for patients with heart failure.

Practitioners should be aware of the limited evidence when considering anti-obesity medications for heart failure patients.

The prevalence of obesity has increased markedly in recent decades, constituting major medical and socioeconomic problems worldwide.

Awareness of the obesity epidemic is crucial for public health initiatives.

The most common adverse events associated with semaglutide are gastrointestinal in nature.

Healthcare providers should inform patients about potential gastrointestinal side effects when prescribing semaglutide.